Nitrous Oxide Abuse: Clinical Outcomes, Pharmacology, Pharmacokinetics, Toxicity and Impact on Metabolism
Open Access
Abstract
The recreational use of nitrous oxide (N2O), also called laughing gas, has increased significantly in recent years. In 2022, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) recognized it as one of the most prevalent psychoactive substances used in Europe. Chronic nitrous oxide (N2O) exposure can lead to various clinical manifestations. The most frequent symptoms are neurological (sensitive or motor disorders), but there are also other manifestations like psychiatric manifestations or cardiovascular disorders (thrombosis events). N2O also affects various neurotransmitter systems, leading to its anesthetic, analgesic, anxiolytic and antidepressant properties. N2O is very challenging to measure in biological matrices. Thus, in cases of N2O intoxication, indirect biomarkers such as vitamin B12, plasma homocysteine and plasma MMA should be explored for diagnosis and assessment. Others markers, like oxidative stress markers, could be promising but need to be further investigated.Keywords
This publication has 77 references indexed in Scilit:
- Nitrous Oxide Determination in Postmortem Biological Samples: A Case of Serial Fatal Poisoning in a Public Hospital*Journal of Forensic Sciences, 2010
- 30 years of dynorphins — New insights on their functions in neuropsychiatric diseasesPharmacology & Therapeutics, 2009
- Nitrous oxide inhibits glutamatergic transmission in spinal dorsal horn neurons ☆Pain, 2008
- Advances in Understanding the Actions of Nitrous OxideAnesthesia Progress, 2007
- Nitrous oxide for relief of labor pain: A systematic reviewAmerican Journal of Obstetrics and Gynecology, 2002
- Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine LevelsArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Risus sardonicus and laughing gas – when nitrous oxide lost its innocenceActa Anaesthesiologica Scandinavica, 1994
- Time course of effects of brief inhalations of nitrous oxide in normal volunteersAddiction, 1994
- Uptake and Excretion of Subanesthetic Concentrations of Nitrous Oxide in ManAnesthesiology, 1962
- TREATMENT OF TETANUS SEVERE BONE-MARROW DEPRESSION AFTER PROLONGED NITROUS-OXIDE ANESTHESIAThe Lancet, 1956